#263 Active ingredient prescribing

18 February 2021

Prescribing medication by its active ingredient became mandatory from 1 February 2021. The active ingredient must be listed first and can be followed by the brand name if the prescriber believes it is clinically necessary.

The goal of this legislation is to help people understand what medicines they are taking, reducing the risk of accidental multiple doses, and to increase the uptake of generic medicines, thereby reducing cost to patients and the PBS.

Exceptions include: 

Prescribing software will require an update and may have some changes to workflows. 

Explaining this change to patients will help prevent confusion, especially for those on long-term or multiple medications.  

A transition period, until 31 July 2021, will allow pharmacies who receive a non-compliant prescription to request the prescriber to reissue it. If reissue is not possible, the pharmacist may still supply and claim for the medicine under the PBS or RPBS. From 1 August 2021, new prescriptions that do not meet active ingredient prescribing requirements cannot be dispensed as PBS prescriptions and will need to be reissued, or dispensed as private prescriptions.

Further information is available from:

This article first appeared on www.mdanational.com.au/advice-and-support/library/blogs/2021/01/active-ingredient-prescribing

AMA Victoria Preferred Suppliers